Table 1.
Epidemiologic and clinical contrasts between KD and MIS-C
KD | MIS-C | |
Locations of highest global incidence | Japan, East Asia | Western Europe, North America and South America |
Racial and ethnic predominance | East Asian heritage | Hispanic and African heritage |
Median age and age range | Median 3–4 yearsTypical range <6mo-6yExtended range 2mo-15y | Median 8–9 yearsRange 1yo-19yo |
Typical clinical features | Fever; and including 3–5 of the following: Rash, Conjunctivitis, Mucositis, Extremity swelling/rash, lymphadenopathy | Fever, Shock and one of the following: Rash, abdominal pain, neurologic changes, conjunctivitis, lymphadenopathya |
Uveitis | Common | Very common and pronouncedb |
Shock | Rare but can occur in KD shock syndrome (5–10% of all KD) | At least 25–50% of cases |
Seasonality of disease | Evident but not associated with a single infectious agent | Clear association with SARS-CoV-2 |
KD, Kawasaki disease; MIS-C, Multisystem Inflammatory Syndrome in Children; SARS, Severe acute respiratory syndrome coronavirus -2.
25–40% of MIS-C meets KD criteria.
Small case series; evidence limited.